The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

89 articles for L Sun


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening.EBI
Harvard Medical School
Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.EBI
Harvard Medical School
Discovery of a Highly Potent, Selective, and Metabolically Stable Inhibitor of Receptor-Interacting Protein 1 (RIP1) for the Treatment of Systemic Inflammatory Response Syndrome.EBI
National Institute of Biological Sciences
An adjustable release rate linking strategy for cytotoxin-peptide conjugates.EBI
Tulane University Health Sciences Center
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing.EBI
Bristol-Myers Squibb Research and Development
Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.EBI
Pharmaron-Beijing
Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II.EBI
National University of Singapore
Fragment-based approach to the design of 5-chlorouracil-linked-pyrazolo[1,5-a][1,3,5]triazines as thymidine phosphorylase inhibitors.EBI
National University of Singapore
Optimization of activity, selectivity, and liability profiles in 5-oxopyrrolopyridine DPP4 inhibitors leading to clinical candidate (Sa)-2-(3-(aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)-N,N-dimethylacetamide (BMS-767778).EBI
Bristol-Myers Squibb
A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities.EBI
National University of Singapore
Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase.EBI
National University of Singapore
Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core.EBI
Bristol-Myers Squibb R & D
Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents.EBI
Institute of Pharmaceutical Industry
7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site.EBI
Bristol-Myers Squibb Research and Development
Aminofurazans as potent inhibitors of AKT kinase.EBI
Glaxosmithkline
Pyrazolone based TGFbetaR1 kinase inhibitors.EBI
Biogen Idec
Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives.EBI
The Chinese Academy of Sciences
Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors.EBI
Glaxosmithkline
Dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur)).EBI
Bristol-Myers Squibb
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.EBI
New York University Medical Center
Recent advances in targeting histone H3 lysine 36 methyltransferases for cancer therapy.EBI
China Pharmaceutical University
Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease.EBI
Texas A&M University
Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties.EBI
H. Lee Moffitt Cancer Center and Research Institute
Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023.EBI
Shenyang Pharmaceutical University
Scaffold hopping derived novel benzoxazepinone receptor-interacting protein kinase 1 (RIP1) inhibitors as anti-necroptosis agents: Anti-inflammatory effect in systemic inflammatory response syndrome (SIRS) and epilepsy.EBI
Ningxia Medical University
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice.EBI
University of Minnesota
Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.EBI
Wyeth Research
Design, synthesis, and biological evaluation of deuterated indolepropionic acid derivatives as novel long-acting pan PPARα/γ/δ agonists.EBI
Guangdong Pharmaceutical University
Design and development of a novel series of oral bivalent BET inhibitors with potent anticancer activities.EBI
Shanghai University
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators.EBI
Shandong University
Discovery of an Anti-TNF-α 9-mer Peptide from a T7 Phage Display Library for the Treatment of Inflammatory Bowel Disease.EBI
Tongji University
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators.EBI
Shandong University
Identification of potent and selective TACE inhibitors via the S1 pocket.EBI
Wyeth Research
Design and synthesis of butynyloxyphenyl beta-sulfone piperidine hydroxamates as TACE inhibitors.EBI
Wyeth Research
Design, Synthesis, and Structure-Activity Relationship Studies of Bisamide Derivatives of Amphotericin B with Potent Efficacy and Low Toxicity.EBI
Shanghai Institute of Materia Medica
Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitors.EBI
Shandong University
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.EBI
Shandong University
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features.EBI
Shandong University
Structural and PK-guided identification of indole-based non-acidic autotaxin (ATX) inhibitors exhibiting high in vivo anti-fibrosis efficacy in rodent model.EBI
Shenyang Pharmaceutical University
Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.EBI
Shandong University
An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.EBI
Shandong University
Synthesis and structural characterization of a monocarboxylic inhibitor for GRB2 SH2 domain.EBI
H. Lee Moffitt Cancer Center and Research Institute
Neuroactive Type-A γ-Aminobutyric Acid Receptor Allosteric Modulator Steroids from the Hypobranchial Gland of Marine Mollusk, EBI
University of Utah
Discovery, optimization, and target identification of novel coumarin derivatives as HIV-1 reverse transcriptase-associated ribonuclease H inhibitors.EBI
Shandong University
2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies.EBI
Shandong University
Discovery of Potent Selective Nonzinc Binding Autotaxin Inhibitor BIO-32546.EBI
Biogen
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs.EBI
Shandong University
Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses.EBI
Shandong University
Hepatoselective Dihydroquinolizinone Bis-acids for HBsAg mRNA Degradation.EBI
Baruch S. Blumberg Institute
Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90-Kinase Interactions.EBI
Chinese Academy of Sciences
Discovery of new small molecule inhibitors targeting isocitrate dehydrogenase 1 (IDH1) with blood-brain barrier penetration.EBI
Chinese Academy of Sciences
Novel lipid side chain modified exenatide analogs emerged prolonged glucoregulatory activity and potential body weight management properties.EBI
China Pharmaceutical University
Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2,4(1H,3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase.EBI
Shandong University
Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitors.EBI
Shandong University
Discovery of Selective Small Molecule Degraders of BRAF-V600E.EBI
Cullgen
Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.EBI
Yanbian University College of Pharmacy
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.EBI
Shandong University
Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.EBI
Sugen
Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.EBI
Huzhou University
Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors.EBI
Instituto De Qu£Mica M£Dica (Iqm-Csic)
Discovery of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups as potential PTP1B inhibitors.EBI
Yanbian University
Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice.EBI
Peking University
Antitumor Activity of Lankacidin Group Antibiotics Is Due to Microtubule Stabilization via a Paclitaxel-like Mechanism.EBI
University of Alberta
Design, synthesis, and biological activity of novel dicoumarol glucagon-like peptide 1 conjugates.EBI
China Pharmaceutical University
Antitumor agents. 139. Synthesis and biological evaluation of thiocolchicine analogs 5,6-dihydro-6(S)-(acyloxy)- and 5,6-dihydro-6(S)-[(aroyloxy)methyl]-1,2,3-trimethoxy-9-(methylthio)-8H- cyclohepta[a]naphthalen-8-ones as novel cytotoxic and antimitotic agents.EBI
University of North Carolina
Synthesis and biological evaluation of NHEBI
Shenyang Pharmaceutical University
Novel fatty acid chain modified GLP-1 derivatives with prolonged in vivo glucose-lowering ability and balanced glucoregulatory activity.EBI
China Pharmaceutical University
Discovery of 4,7-Diamino-5-(4-phenoxyphenyl)-6-methylene-pyrimido[5,4- b]pyrrolizines as Novel Bruton's Tyrosine Kinase Inhibitors.EBI
China Pharmaceutical University
5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.EBI
Shandong University
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.EBI
Shandong University
A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects.EBI
China Pharmaceutical University
Design, synthesis and pharmacological evaluation of 4,5-diarylisoxazols bearing amino acid residues within the 3-amido motif as potent heat shock protein 90 (Hsp90) inhibitors.EBI
China Pharmaceutical University
Phosphonate linkers and their use to facilitate cellular retention of compoundsBDB
Merck Sharp & Dohme
Heteroaryl compounds as 5-HT4 receptor ligandsBDB
Suven Life Sciences
Amidoethyl azole orexin receptor antagonistsBDB
Merck Sharp & Dohme
Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereofBDB
Innov17
P2X7 modulatorsBDB
Janssen Pharmaceutica
Cyclopropanamine compound and use thereofBDB
Takeda Pharmaceutical
Enhancer of zeste homolog 2 inhibitorsBDB
Glaxosmithkline
Synthesis and characterization of phenolic Mannich bases and effects of these compounds on human carbonic anhydrase isozymes I and II.BDB
Dumlupinar University
Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer.BDB
Universit�� Lille Nord De France
Buprenorphine analogsBDB
Purdue Pharma
HIV protease inhibitorsBDB
Merck Canada
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.BDB
Albany Medical College
Targeting NAD biosynthesis in bacterial pathogens: Structure-based development of inhibitors of nicotinate mononucleotide adenylyltransferase NadD.BDB
Burnham Institute For Medical Research
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors.BDB
Dupont Pharmaceuticals
Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infectionBDB
Hoffmann-La Roche